NASDAQ$BTSG

Brightspring Health Services Inc · Q2 2025 earnings

Q2 2025 earnings ·

Briefing

BrightSpring Health Services reported Q2 2025 revenue of $3.15B, net income of $27.5M.

For Q2 2025, BrightSpring Health Services reported Revenue was $3.15B, net income was $27.5M. Management discusses segment trends, liquidity, and outlook in the quarterly filing.

  • Revenue $3.15B for Q2 2025.
  • Net income $27.5M.
  • MD&A highlights operating priorities, liquidity, and sector risks.

Headline financials

Total Revenue

$3.15B

Previous: $2.73B+15.3%
EPS

$0.13

Previous: $0.10+30.0%
Capital Expenditures

-$42.1M

Previous: -$45.6M+7.7%
Free Cash Flow

-$13.8M

Previous: -$25.6M+46.0%
Net Income

$28.2M

Previous: $19.9M+41.6%
Operating Income

$48.6M

Previous: $62.4M-22.2%
Gross Profit

$375M

Previous: $389M-3.6%
Cash & Equivalents

$70.1M

Previous: $25M+180.0%
Total Assets

$5.94B

Previous: $5.61B+6.0%

Revenue & EPS history

Brightspring Health Services Inc · Revenue · Quarterly

$3.15B

Q2 2025+15.3%vs Q2 2024
Beat estimate in 2 of 2 quarters(100%)
ActualEstimate

Forward guidance

The quarterly filing discusses operating priorities, liquidity, and sector risks.

Tailwinds

  • MD&A outlines strategic priorities and capital allocation.
  • Segment commentary supports the earnings narrative.

Headwinds

  • Macro, rates, or input costs may pressure margins.
  • One-time items can affect year-over-year comparability.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

+4.4%

Avg return

Earnings day

+7.8%

Avg return

5 days after

+15.8%

Avg return

30 days after

75%

6 / 8 earnings

Positive

+16.6%

Q1 2025

Best reaction

-8.7%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+9.6%+9.9%+28.5%
Q4 2025+3.2%+4.6%+5.5%
Q3 2025+0.5%-2.3%+7.8%
Q2 2025-4.9%-0.7%+14.7%
Q1 2025+16.6%+28.7%+33.0%
Q3 2024+15.2%+22.6%+28.9%
Q2 2024-8.7%-8.1%+2.6%
Q1 2024+3.8%+7.7%+5.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro